Related Experiment Video

Updated: Mar 19, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.3K

Dysregulation of HIF2α and autophagy in renal cell carcinoma

Xian-De Liu1, Haifeng Zhu2, Adela DePavia1

  • 1Department of Genitourinary Medical Oncology; The University of Texas MD Anderson Cancer Center ; Houston, TX USA.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Autophagy and proteasomes work together to degrade the EPAS1 protein, a process crucial for understanding renal cell carcinoma development. This discovery sheds light on cancer biology and potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • Autophagy and proteasome pathways are critical for cellular protein degradation.
  • Endothelial PAS domain-containing protein 1 (EPAS1, also known as HIF2α) is implicated in various cancers.
  • Dysregulation of autophagy is frequently observed in renal cell carcinoma (RCC).

Purpose of the Study:

  • To investigate the interplay between autophagy and proteasomes in EPAS1 degradation.
  • To elucidate the role of Von Hippel-Lindau (VHL) and sequestosome 1 (SQSTM1/p62) in this process.
  • To understand the implications for renal cell carcinoma pathogenesis.

Main Methods:

  • Utilized molecular biology techniques to study protein degradation pathways.
  • Investigated the interaction between autophagy, proteasomes, EPAS1, VHL, and SQSTM1/p62.
  • Analyzed the relevance of these pathways in the context of renal cell carcinoma.

Main Results:

  • Demonstrated that autophagy collaborates with proteasomes to degrade EPAS1.
  • Showed this degradation is dependent on Von Hippel-Lindau (VHL) and sequestosome 1 (SQSTM1/p62).
  • Highlighted the significance of these findings for understanding RCC.

Conclusions:

  • Autophagy and proteasomes cooperatively regulate EPAS1 levels via VHL and SQSTM1/p62.
  • This regulatory mechanism is relevant to the pathogenesis of renal cell carcinoma.
  • Further research into this pathway may reveal novel therapeutic strategies for RCC.
Keywords:
HIF2αVHLautophagyp53p62proteasomerenal cell carcinoma

More Related Videos

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells06:23

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

629
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

896

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K